No Data
No Data
Express News | Mckesson Corp : UBS Raises Target Price to $670 From $630
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $596
Barclays analyst Stephanie Davis maintains $McKesson(MCK.US)$ with a buy rating, and maintains the target price at $596.According to TipRanks data, the analyst has a success rate of 42.1% and a
McKesson (MCK) Receives a Buy From Barclays
Investors Appear Satisfied With McKesson Corporation's (NYSE:MCK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may consider McKesson Corporation (NYSE:MCK) as a stock to potentially avoid with its 25
Looking Into McKesson's Recent Short Interest
McKesson's (NYSE:MCK) short percent of float has fallen 10.63% since its last report. The company recently reported that it has 1.85 million shares sold short, which is 1.43% of all regular shares
No Data
JamieOliver : Large shogata